Login / Signup

Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate.

Akiyuki YamamotoMasashi KatoHirotaka MatsuiRyo IshidaTohru KimuraYasuhito FunahashiNaoto SassaYoshihisa MatsukawaOsamu KamihiraRyohei HattoriMomokazu GotohToyonori Tsuzuki
Published in: International journal of clinical oncology (2018)
The presence of IDC-P is an independent prognostic factor in CRPC patients with distant metastases and IDC-P in needle biopsies at the time of initial diagnosis. Docetaxel may prolong CSS and OS in CRPC patients with distant metastases and IDC-P in needle biopsies at the time of initial diagnosis.
Keyphrases
  • ultrasound guided
  • prognostic factors
  • lymph node
  • prostate cancer
  • locally advanced
  • squamous cell carcinoma
  • rectal cancer